- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SMV reorganizes upper management
Nuclear medicine vendor SMV has revamped its executive lineup,a move that has resulted in the departure of Colin McNaught, chairmanand CEO of the vendor's SMV America unit in Twinsburg OH, andAndre Debionne, chairman and CEO of the holding company for
Nuclear medicine vendor SMV has revamped its executive lineup,a move that has resulted in the departure of Colin McNaught, chairmanand CEO of the vendor's SMV America unit in Twinsburg OH, andAndre Debionne, chairman and CEO of the holding company for SMVAmerica and SMV International.
SMV spokesperson Robert Ripley said that Debionne's positionwas a transitional one designed to help smooth the integrationof SMV's predecessors, Sopha and Summit Nuclear, while McNaughtdeparted for personal reasons. McNaught previously was head ofSopha's U.S. unit.
Neither McNaught nor Debionne will be replaced, according toRipley. SMV International chief executive Jean Plazenet will assumethe responsibilities of both executives. Summit veteran RandallSommerdyke remains president of SMV America, Ripley said.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
